1. Home
  2. KDLY vs LRE Comparison

KDLY vs LRE Comparison

Compare KDLY & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KDLY
  • LRE
  • Stock Information
  • Founded
  • KDLY 2019
  • LRE 2001
  • Country
  • KDLY United States
  • LRE Japan
  • Employees
  • KDLY N/A
  • LRE N/A
  • Industry
  • KDLY
  • LRE
  • Sector
  • KDLY
  • LRE
  • Exchange
  • KDLY NYSE
  • LRE Nasdaq
  • Market Cap
  • KDLY 10.9M
  • LRE 17.6M
  • IPO Year
  • KDLY 2024
  • LRE 2023
  • Fundamental
  • Price
  • KDLY $3.78
  • LRE $1.16
  • Analyst Decision
  • KDLY
  • LRE
  • Analyst Count
  • KDLY 0
  • LRE 0
  • Target Price
  • KDLY N/A
  • LRE N/A
  • AVG Volume (30 Days)
  • KDLY 184.1K
  • LRE 8.7K
  • Earning Date
  • KDLY 05-13-2025
  • LRE 01-01-0001
  • Dividend Yield
  • KDLY N/A
  • LRE N/A
  • EPS Growth
  • KDLY N/A
  • LRE N/A
  • EPS
  • KDLY N/A
  • LRE 0.29
  • Revenue
  • KDLY $2,719,840.00
  • LRE $117,804,154.00
  • Revenue This Year
  • KDLY N/A
  • LRE N/A
  • Revenue Next Year
  • KDLY N/A
  • LRE N/A
  • P/E Ratio
  • KDLY N/A
  • LRE $4.22
  • Revenue Growth
  • KDLY N/A
  • LRE 8.82
  • 52 Week Low
  • KDLY $0.65
  • LRE $1.10
  • 52 Week High
  • KDLY $5.25
  • LRE $13.76
  • Technical
  • Relative Strength Index (RSI)
  • KDLY N/A
  • LRE 43.17
  • Support Level
  • KDLY N/A
  • LRE $1.22
  • Resistance Level
  • KDLY N/A
  • LRE $1.29
  • Average True Range (ATR)
  • KDLY 0.00
  • LRE 0.15
  • MACD
  • KDLY 0.00
  • LRE -0.01
  • Stochastic Oscillator
  • KDLY 0.00
  • LRE 10.56

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

Share on Social Networks: